Clinical Trials · NCT02324842
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Enrollment
- 45
- Start date
- Nov 2014
- Locations
- 1 site, United States
- Primary endpoint
- HbA1c at 4 Months